NDC 43742-1507-1 Female Stimulant

Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (suis), Kreosotum, Oophorinum (suis), Uterus (suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (suis), Hypophysis Suis, Aconiticum Acidum Cis-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (alkaligenes), Mutabile Bacillus (bach)

NDC Package Code 43742-1507-1

The NDC Code 43742-1507-1 is assigned to a package of 30 ml in 1 bottle, dropper of Female Stimulant, a human over the counter drug labeled by Deseret Biologicals, Inc.. The product's dosage form is liquid and is administered via oral form.

Field Name Field Value
NDC Code 43742-1507-1
Package Description 30 mL in 1 BOTTLE, DROPPER
Proprietary Name Female Stimulant What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (suis), Kreosotum, Oophorinum (suis), Uterus (suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (suis), Hypophysis Suis, Aconiticum Acidum Cis-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (alkaligenes), Mutabile Bacillus (bach) What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 43742150701 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Product Type Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Deseret Biologicals, Inc.
Dosage Form Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s)
  • Oral - Administration to or by way of the mouth.
Active Ingredient(s)
  • LILIUM LANCIFOLIUM WHOLE FLOWERING 4 [hp_X]/mL
  • LYCOPERDON UTRIFORME FRUITING BODY 6 [hp_X]/mL
  • CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT 6 [hp_X]/mL
  • GOLDENSEAL 6 [hp_X]/mL
  • PETROSELINUM CRISPUM 6 [hp_X]/mL
  • AQUILEGIA VULGARIS 8 [hp_X]/mL
  • SUS SCROFA UMBILICAL CORD 8 [hp_X]/mL
  • SUS SCROFA ADRENAL GLAND 8 [hp_X]/mL
  • PORK HEART 8 [hp_X]/mL
  • WOOD CREOSOTE 8 [hp_X]/mL
  • SUS SCROFA OVARY 8 [hp_X]/mL
  • SUS SCROFA UTERUS 8 [hp_X]/mL
  • ESTRONE 8 [hp_X]/mL
  • SUS SCROFA PITUITARY GLAND 10 [hp_X]/mL
  • ACONITIC ACID, (Z)- 10 [hp_X]/mL
  • LACHESIS MUTA VENOM 10 [hp_X]/mL
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 10 [hp_X]/mL
  • MERCURIUS SOLUBILIS 12 [hp_X]/mL
  • SEPIA OFFICINALIS JUICE 13 [hp_X]/mL
  • SUS SCROFA PINEAL GLAND 16 [hp_X]/mL
  • APIS MELLIFERA VENOM 18 [hp_X]/mL
  • ESTRADIOL 30 [hp_X]/mL
  • PROGESTERONE 30 [hp_X]/mL
  • TESTOSTERONE 30 [hp_X]/mL
  • SUS SCROFA PLACENTA 6 [hp_C]/mL
  • ALCALIGENES FAECALIS 30 [hp_C]/mL
  • ESCHERICHIA COLI 30 [hp_C]/mL
DEA Schedule Schedule III (CIII) Substances What is the Drug Enforcement Administration (DEA) CIII Schedule?
The controlled substances in the CIII schedule have an abuse potential and dependence liability less than those in schedules CI and CII, and have an accepted medical use in the United States. Schedule CIII controlled substances include preparations containing limited quantities of certain narcotic drugs, and other nonnarcotic drugs such as: derivatives of barbituric acid, except those that are listed in another schedule, glutethimide (Doriden), methyprylon (Noludar), nalorphine, benzphetamine, chlorphentermine, clortermine, and phendimetrazine.
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category UNAPPROVED HOMEOPATHIC - What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date 08-20-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

NDC Code Structure

  • 43742 - Deseret Biologicals, Inc.
    • 43742-1507 - Female Stimulant
      • 43742-1507-1 - 30 mL in 1 BOTTLE, DROPPER

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.